Wesfarmers Limited’s A$770 Million Acquisition Of Australian Pharmaceutical Industries Limited

Ashurst has advised Australian Pharmaceutical Industries Limited on the deal. API, Wesfarmers and Wesfarmers Limited (Wesfarmers Parent) has entered into a Scheme Implementation Deed (SID), pursuant...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here